Camille Tlemsani

1.9k total citations
52 papers, 881 citations indexed

About

Camille Tlemsani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Camille Tlemsani has authored 52 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Camille Tlemsani's work include Sarcoma Diagnosis and Treatment (16 papers), Cancer Genomics and Diagnostics (10 papers) and Nutrition and Health in Aging (6 papers). Camille Tlemsani is often cited by papers focused on Sarcoma Diagnosis and Treatment (16 papers), Cancer Genomics and Diagnostics (10 papers) and Nutrition and Health in Aging (6 papers). Camille Tlemsani collaborates with scholars based in France, United States and Italy. Camille Tlemsani's co-authors include Pascaline Boudou‐Rouquette, François Goldwasser, Olivier Huillard, Olivier Mir, Stanislas Ropert, Julie Giroux, Nicolas Barry Delongchamps, Marc Zerbib, Michaël Peyromaure and Jennifer Arrondeau and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Camille Tlemsani

41 papers receiving 867 citations

Peers

Camille Tlemsani

ONCOL

PRM

PHYSI

PFM

Francesca Del Monte Italy

Hoon‐Gu Kim South Korea

Shozo Ide Japan

Atsushi Osoegawa Japan

Ángel Segura Spain

Karen Mulder Canada

Aart Beeker Netherlands

Antonia Strippoli Italy

J. Alexandre France

Hei Cheul Jeung South Korea

Francesca Del Monte Italy

Camille Tlemsani

458 ×1.1

ONCOL

168 ×0.6

PRM

306 ×1.2

70 ×0.4

PHYSI

91 ×0.8

PFM

Citations per year, relative to Camille Tlemsani Camille Tlemsani (= 1×) peers Francesca Del Monte

Countries citing papers authored by Camille Tlemsani

Since Specialization

Citations

This map shows the geographic impact of Camille Tlemsani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Tlemsani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Tlemsani more than expected).

Fields of papers citing papers by Camille Tlemsani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Tlemsani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Tlemsani. The network helps show where Camille Tlemsani may publish in the future.

Co-authorship network of co-authors of Camille Tlemsani

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Tlemsani. A scholar is included among the top collaborators of Camille Tlemsani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Tlemsani. Camille Tlemsani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taly, Valérie, Camille Tlemsani, Pascaline Boudou‐Rouquette, et al.. (2025). Droplet Digital PCR Assay for Detection and Monitoring of Universally Methylated ctDNA in Patients with Sarcoma. Clinical Cancer Research. 31(18). 3944–3955.

Brahmi, Mehdi, Maud Toulmonde, Sarah Winter, et al.. (2025). Ostéosarcome et sarcome d’Ewing récurrents ou réfractaires – Directives françaises des groupes FSG/NETSARC et GroupOs. Bulletin du Cancer. 112(6). 601–610.

Jouinot, Anne, Nadim Hamzaoui, Olivier Huillard, et al.. (2025). Predisposition to prostate cancer and clinical implications in a real-life cohort. European Journal of Human Genetics. 33(9). 1163–1172.

Elloumi, Fathi, Camille Tlemsani, Christine M. Heske, et al.. (2025). Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line data. STAR Protocols. 6(4). 104076–104076.

Masci, Giorgio Maria, Guillaume Chassagnon, Marco Alifano, et al.. (2024). Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patients. European Journal of Radiology. 179. 111667–111667.

Bottosso, Michele, Benjamin Verret, Olivier Caron, et al.. (2024). Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO Precision Oncology. 8(8). e2400139–e2400139. 3 indexed citations

Tlemsani, Camille, Christine M. Heske, Fathi Elloumi, et al.. (2024). Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines. iScience. 27(6). 109781–109781. 2 indexed citations

Penel, Nicolas, Sylvie Bonvalot, Marie‐Cécile Le Deley, et al.. (2023). Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis value. International Journal of Cancer. 153(2). 407–416. 8 indexed citations

Marisa, Laëtitia, et al.. (2023). Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers?. JCO Precision Oncology. 7(7). e2200582–e2200582. 1 indexed citations

10.

Tlemsani, Camille, Fréderique Larousserie, Vincent Audard, et al.. (2023). Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options. International Journal of Molecular Sciences. 24(2). 1361–1361. 19 indexed citations

11.

Boudou‐Rouquette, Pascaline, Anne Jouinot, Nihel Khoudour, et al.. (2022). Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients. Pharmaceutics. 14(6). 1224–1224. 6 indexed citations

12.

Tlemsani, Camille, Jean-Philippe Durand, Bruno Raynard, et al.. (2022). Relationship between the creatinine/cystatin C ratio and muscle mass measured by CT-scan in cancer patients. Clinical Nutrition ESPEN. 51. 412–418. 15 indexed citations

13.

Bellesœur, Audrey, Anne Jouinot, Camille Tlemsani, et al.. (2021). Prevalence of drug–drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management. Cancer Chemotherapy and Pharmacology. 88(4). 741–751. 4 indexed citations

14.

Tlemsani, Camille, Lőrinc Sándor Pongor, Fathi Elloumi, et al.. (2020). SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures. Cell Reports. 33(3). 108296–108296. 92 indexed citations

15.

Jouinot, Anne, Jean-Philippe Durand, Pascaline Boudou‐Rouquette, et al.. (2019). Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients. Clinical Nutrition. 39(6). 1893–1899. 26 indexed citations

16.

Huillard, Olivier, Anne Jouinot, Camille Tlemsani, et al.. (2019). Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial. Thyroid. 29(12). 1820–1827. 12 indexed citations

17.

Bretagne, Marie, Pascaline Boudou‐Rouquette, Olivier Huillard, et al.. (2016). Inhibiteurs de tyrosine kinase ciblant l’angiogenèse et sujets âgés : tolérance, évaluation pré-thérapeutique et gestion des effets indésirables. Bulletin du Cancer. 103(3). 259–272. 4 indexed citations

18.

Bretagne, Marie, Anne Jouinot, Jean-Philippe Durand, et al.. (2016). Estimation of glomerular filtration rate in patients with abnormal body composition and relation with carboplatin toxicity. Annals of Oncology. 27. vi509–vi509. 1 indexed citations

19.

Arrondeau, Jennifer, Olivier Huillard, Camille Tlemsani, et al.. (2015). Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics. Expert Opinion on Investigational Drugs. 24(5). 673–687. 7 indexed citations

20.

Huillard, Olivier, Olivier Mir, Michaël Peyromaure, et al.. (2013). Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. British Journal of Cancer. 108(5). 1034–1041. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact